IE
ARMP icon

Israel Englander’s Armata Pharmaceuticals ARMP Stock Holding History

Israel Englander’s Portfolio ARMP Stock Details ARMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.05M Buy
470,500
+212,508
+82% +$1.95M ﹤0.01% 3459
2026
Q1 		$2.64M Buy
257,992
+231,904
+889% +$1.95M ﹤0.01% 3602
2025
Q4 		$164K Buy
+26,088
New +$143K ﹤0.01% 5524
2023
Q2 		– Sell
-11,130
Closed -$19K – 6085
2023
Q1 		$19K Sell
11,130
-4,455
-29% -$10.3K ﹤0.01% 5875
2022
Q4 		$19K Buy
+15,585
New +$40.6K ﹤0.01% 6059
2021
Q3 		– Sell
-10,055
Closed -$40K – 6754
2021
Q2 		$40K Sell
10,055
-5,346
-35% -$22.5K ﹤0.01% 6391
2021
Q1 		$74K Buy
+15,401
New +$75.7K ﹤0.01% 5732
2015
Q4 		– Sell
-73
Closed -$40K – 3397
2015
Q3 		$40K Buy
+73
New +$66.7K ﹤0.01% 3361

Other funds holding ARMP

MAM
Madison Asset Management Madison, Wisconsin $8.39B AUM 16.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Edgewood Management
Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Israel Englander's ARMP Position: Q2 2026 in Review

Israel Englander increased its Armata Pharmaceuticals (ARMP) stake by 82% in Q2 2026, buying an estimated $1.95M and bringing the position to 470,500 shares worth $3.05M. The position accounts for ﹤0.01% of the portfolio, ranked #3459.

Israel Englander first reported a position in ARMP in Q3 2015 and has held it in 8 quarters since. 53 funds tracked by Wall St. Rank hold ARMP as of Q2 2026.

  • Israel Englander held 470,500 shares of Armata Pharmaceuticals worth $3.05M as of Q2 2026.
  • Israel Englander bought 212,508 Armata Pharmaceuticals shares in Q2 2026, an estimated $1.95M.
  • Armata Pharmaceuticals made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #3459 holding.
  • Israel Englander first reported a position in Armata Pharmaceuticals in Q3 2015 and has held it in 8 quarters since.
  • 53 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.